Are Age and Sex Predictors of Malignancy in Cytologically Indeterminate Thyroid Nodules?

被引：0
|
作者：
Jafari, Pari [1 ]
Johnson, Daniel [2 ]
Cavallo, Allison [3 ]
Uraizee, Imran [4 ]
Vaghaiwalla, Tanaz [5 ]
Angelos, Peter [4 ]
Antic, Tatjana [4 ]
Cipriani, Nicole [4 ]
机构：
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Mem Hosp Syst, Mchenry, IL USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
380
引用
收藏
页码：377 / 378
页数：2
相关论文
共 50 条
  • [41] Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Patrick D. Chin
    Catherine Y. Zhu
    Dipti P. Sajed
    Gregory A. Fishbein
    Michael W. Yeh
    Angela M. Leung
    Masha J. Livhits
    Endocrine Pathology, 2020, 31 : 377 - 384
  • [42] Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Chin, Patrick D.
    Zhu, Catherine Y.
    Sajed, Dipti P.
    Fishbein, Gregory A.
    Yeh, Michael W.
    Leung, Angela M.
    Livhits, Masha J.
    ENDOCRINE PATHOLOGY, 2020, 31 (04) : 377 - 384
  • [43] Ultrasound radiomics and genomics improve the diagnosis of cytologically indeterminate thyroid nodules
    Chen, Lu
    Zhang, Mingbo
    Luo, Yukun
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [44] OVERVIEW OF MOLECULAR BIOMARKERS FOR ENHANCING THE MANAGEMENT OF CYTOLOGICALLY INDETERMINATE THYROID NODULES AND THYROID CANCER
    Duick, Daniel S.
    ENDOCRINE PRACTICE, 2012, 18 (04) : 611 - 615
  • [45] BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
    Pongsapich, Warut
    Chongkolwatana, Cheerasook
    Poungvarin, Naravat
    Amornpichetkul, Kanchana
    Piyawattayakorn, Nutthaya
    Vejvisithsakul, Pichpisith
    Maneeprasopchoke, Prachya
    ONCOTARGETS AND THERAPY, 2019, 12 : 1465 - 1473
  • [46] UTILITY OF CORRELATION BETWEEN TI-RADS AND BETHESDA CLASSIFICATION TO ESTIMATE RISK OF MALIGNANCY FOR CYTOLOGICALLY INDETERMINATE THYROID NODULES
    Chereau, N.
    Menegaux, F.
    Bertin, J-B
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [47] Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
    Polavarapu, Preethi
    Fingeret, Abbey
    Yuil-Valdes, Ana
    Olson, Daniel
    Patel, Anery
    Shivaswamy, Vijay
    Matthias, Troy D.
    Goldner, Whitney
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (11)
  • [48] Serum TSH as a predictor of malignancy in indeterminate thyroid nodules
    Amado, A.
    Castro, B.
    Torre, A. P.
    Graca, S.
    Tavares, A.
    Povoa, A.
    Soares, C.
    Goncalves, G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2022, 104 (05) : 380 - 384
  • [49] Incidence and malignancy rates of indeterminate pediatric thyroid nodules
    Wang, Huiying
    Mehrad, Mitra
    Ely, Kim A.
    Liang, Jiancong
    Solorzano, Carmen C.
    Neblett, Wallace W.
    Coogan, Alice C.
    Weiss, Vivian L.
    CANCER CYTOPATHOLOGY, 2019, 127 (04) : 231 - 239
  • [50] Predictors of Malignancy in Children with Thyroid Nodules
    Mussa, Alessandro
    De Andrea, Maurilio
    Motta, Manuela
    Mormile, Alberto
    Palestini, Nicola
    Corrias, Andrea
    JOURNAL OF PEDIATRICS, 2015, 167 (04): : 886 - +
12345